Peptides homologous to Cys53 44–77 and Cys53 52–77 of the human growth hormone molecule were prepared by solid-phase synthesis and tested by our acute glucose tolerance test in ob/ob mice. Peptide 44–77, as either the Acm-Cys53 or Cam-Cys53 derivative, adversely affects glucose tolerance at doses of 100 to 150 nmol. Peptide 52–77 is nonhyperglycemic. Other diabetogenic properties are being tested.
This content is only available via PDF.
Copyright © 1978 by the American Diabetes Association
1978